T. Stegall

Experimental Myasthenia Gravis Influence the Severity and Course of Protein 1: A Chemokine with the Potential to Up-Regulating Monocyte Chemoattractant with the Acetylcholine Receptor by Muscle Responds to an Antibody Reactive

S. Reyes-Reyna, K. Krolick, T. Stegall, 2002 .

Muscle Responds to an Antibody Reactive with the Acetylcholine Receptor by Up-Regulating Monocyte Chemoattractant Protein 1: A Chemokine with the Potential to Influence the Severity and Course of Experimental Myasthenia Gravis1

S. Reyes-Reyna, K. Krolick, T. Stegall, 2002, The Journal of Immunology.

Myocytes respond in vivo to an antibody reactive with the acetylcholine receptor by upregulating interleukin-15: an interferon-gamma activator with the potential to influence the severity and course of experimental myasthenia gravis

K. Krolick, T. Stegall, 2001, Journal of Neuroimmunology.

Myocytes respond to both interleukin-4 and interferon-gamma: cytokine responsiveness with the potential to influence the severity and course of experimental myasthenia gravis.

K. Krolick, T. Stegall, 2000, Clinical immunology.

A monoclonal lewis rat myocyte line that responds to interferon-gamma: responsiveness with the potential to influence subsequent interactions with the immune system.

K. Krolick, T. Stegall, 2000, Clinical immunology.